ALPHA TRIBE

Shilpa Medicare LimitedUpdates, 14-02-2026: General Updates

14-02-2026 | 03:42 pm

Shilpa Medicare partnered with NXI Therapeutics AG for long-term development and manufacturing of a New Chemical Entity for autoimmune disorders. This third international mandate reinforces its CDMO platform, expanding capabilities in innovative therapies and offering long-term growth potential.

No comments yet. Be the first to comment!

All announcements from Shilpa Medicare Limited